Effects of Tiotropium on Walking Capacity in Patients With COPD

Summary

This study was designed to test the following hypothesis: A) The acute and long-term (3 weeks) bronchodilator-induced changes in exercise tolerance and in the physiological response during the endurance shuttle walk will be greater with tiotropium compared to placebo in COPD patients. B) Three weeks of bronchodilation will be associated with increase activity of daily living as evaluated using the London Chest Activity Daily Living scale.

Timeline

Start

2005-04

Primary completion

—

Completion

2010-08

Drugs

Indications